$DYAI
DYADIC INTERNATIONAL INC Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924034545 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$1.958M
YoY Change		393.0%
Cost Of Revenue		$395.9K
YoY Change		273.95%
Gross Profit		$1.562M
YoY Change		436.28%
Gross Profit Margin		79.78%
Selling, General & Admin		$1.298M
YoY Change		1.4%
% of Gross Profit		83.12%
Research & Development		$460.2K
YoY Change		-35.75%
% of Gross Profit		29.47%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$460.2K
YoY Change		-35.75%
Operating Profit		-$202.6K
YoY Change		-88.22%
Interest Expense		-$6.850K
YoY Change		-106.47%
% of Operating Profit
Other Income/Expense, Net		-$846.00
YoY Change		-100.8%
Pretax Income		-$203.5K
YoY Change		-87.36%
Income Tax
% Of Pretax Income
Net Earnings		-$203.5K
YoY Change		-87.4%
Net Earnings / Revenue		-10.39%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share		-$0.01
COMMON SHARES
Basic Shares Outstanding	29.59M	29.48M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$9.922M
YoY Change		21.3%
Cash & Equivalents		$5.922M
Short-Term Investments		$4.001M
Other Short-Term Assets		$374.2K
YoY Change		-22.04%
Inventory
Prepaid Expenses
Receivables		$352.9K
Other Receivables		$40.84K
Total Short-Term Assets		$10.69M
YoY Change		17.63%
LONG-TERM ASSETS
Property, Plant & Equipment		$104.9K
YoY Change		-30.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$10.33K
YoY Change		-29.19%
Total Long-Term Assets		$115.2K
YoY Change		-31.28%
TOTAL ASSETS
Total Short-Term Assets		$10.69M
Total Long-Term Assets		$115.2K
Total Assets		$10.81M
YoY Change		16.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$561.8K
YoY Change		-6.39%
Accrued Expenses		$839.4K
YoY Change		35.34%
Deferred Revenue		$514.5K
YoY Change		3602.12%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$2.077M
YoY Change		42.53%
LONG-TERM LIABILITIES
Long-Term Debt		$5.268M
YoY Change
Other Long-Term Liabilities		$48.09K
YoY Change		-67.94%
Total Long-Term Liabilities		$5.316M
YoY Change		3444.25%
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.077M
Total Long-Term Liabilities		$5.316M
Total Liabilities		$7.394M
YoY Change		361.22%
SHAREHOLDERS EQUITY
Retained Earnings		-$84.54M
YoY Change		8.09%
Common Stock		$41.84K
YoY Change		1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$18.90M
YoY Change		-0.16%
Treasury Stock Shares
Shareholders Equity		$3.412M
YoY Change
Total Liabilities & Shareholders Equity		$10.81M
YoY Change		16.75%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$203.5K
YoY Change		-87.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$201.1K
YoY Change		-89.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$11.98K
YoY Change		-100.34%
Cash From Investing Activities		-$11.98K
YoY Change		-100.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change
NET CHANGE
Cash From Operating Activities		-201.1K
Cash From Investing Activities		-11.98K
Cash From Financing Activities		0.000
Net Change In Cash		-213.0K
YoY Change		-113.57%
FREE CASH FLOW
Cash From Operating Activities		-$201.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	DYADIC INTERNATIONAL INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001213809
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41842873
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41064563
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29589371
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28811061
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1	pure
CY2024Q3	ecd	Trd Arr Adoption Date TrdArrAdoptionDate	September 4, 2024
CY2024Q3	ecd	Trd Arr Ind Title TrdArrIndTitle	Chief Operating Officer
CY2024Q3	ecd	Trd Arr Ind Name TrdArrIndName	Joseph Hazelton
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2024Q3	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	81270
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55264
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0486747
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1044 North U.S. Highway One, Suite 201
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	743-8333
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	DYAI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29589371
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5921614	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515028	usd
CY2024Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000832	usd
CY2023Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	748290	usd
CY2024Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	40835	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	10083	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	352934	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	466159	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	374209	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	327775	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	10690424	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	8067335	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	104914	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141439	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10328	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10462	usd
CY2024Q3	us-gaap	Assets Assets	10805666	usd
CY2023Q4	us-gaap	Assets Assets	8219236	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	561797	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	656445	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	839420	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1057164	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	514483	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	490113	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	53476	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48059	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2077176	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2251781	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	48091	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	88870	usd
CY2024Q3	us-gaap	Liabilities Liabilities	7393554	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2340651	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	41843	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	41065	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	106835784	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	105044756	usd
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84535600	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80277321	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	3412112	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5878585	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10805666	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8219236	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1957500	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	397060	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2678013	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2212271	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	395894	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	105869	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	841805	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1625731	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	460241	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	716351	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1498593	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2444469	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1297984	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1282361	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4694334	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4164970	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-5995	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-12600	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-14044	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-38143	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	2160114	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	2117181	usd
	us-gaap	Costs And Expenses CostsAndExpenses	7048776	usd
	us-gaap	Costs And Expenses CostsAndExpenses	8273313	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-202614	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1720121	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4370763	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6061042	usd
CY2024Q3	dyai	Interest Income Nonoperating InterestIncomeNonoperating	127331	usd
CY2023Q3	dyai	Interest Income Nonoperating InterestIncomeNonoperating	105862	usd
	dyai	Interest Income Nonoperating InterestIncomeNonoperating	353245	usd
	dyai	Interest Income Nonoperating InterestIncomeNonoperating	319787	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	60977	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1017592	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-846	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	105862	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	112484	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1337379	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-203460	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1614259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4258279	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4723663	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2024Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29503143
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28811061
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29225861
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28794712
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5878585	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	306478	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	340335	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2009596	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	4515802	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	297603	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	400000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2045223	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	3168182	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	247390	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	200000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-203460	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	3412112	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11087739	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	330639	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	342186	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-956444	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10804120	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	334316	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2152960	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8985476	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	281307	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1614259	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7652524	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4258279	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4723663	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	851471	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	946262	usd
	dyai	Investment Income Amortization Accretion Of Premium InvestmentIncomeAmortizationAccretionOfPremium	-52037	usd
	dyai	Investment Income Amortization Accretion Of Premium InvestmentIncomeAmortizationAccretionOfPremium	-47516	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43961	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	60977	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1017592	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14044	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-38143	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	30752	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-48463	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-114814	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	107666	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46386	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91537	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1163	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4946	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-109426	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-691471	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	121623	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7347	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	24370	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-132353	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-26846	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3278411	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5803375	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	5971505	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	2251018	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	2771000	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	8373000	usd
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	60977	usd
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	1293760	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3139528	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7415742	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5824326	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	199	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3463	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-593414	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1608904	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6515028	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5794272	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5921614	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7403176	usd
	dyai	Vesting Of Restricted Stock VestingOfRestrictedStock	664086	usd
	dyai	Vesting Of Restricted Stock VestingOfRestrictedStock	342186	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	600000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	149778	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	156983	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Estimates inherent in the preparation of these consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, estimates related to revenue recognition, accrued expenses, stock-based compensation expense, and income taxes. The Company bases its estimates on historical experience and other market specific or other relevant assumptions it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. Actual results <em style="font: inherit;"> may </em>differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b><i>Concentrations and Credit Risk</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, investment securities, and accounts receivable. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company currently deals with <em style="font: inherit;">four</em> reputable financial institutions and has <em style="font: inherit;">not</em> experienced any losses in those accounts. </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="background-color:#ffffff;">For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, the Company’s revenue was generated from </span><span style="-sec-ix-hidden:c120651066"><span style="background-color:#ffffff;">t</span>en</span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650890">seven</span><span style="background-color:#ffffff;"> customers, respectively. For the </span><em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, the Company’s revenue was generated from </span><span style="-sec-ix-hidden:c120650894">sixteen</span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650895">thirteen</span><span style="background-color:#ffffff;"> customers, respectively. Significant customers are those that account for greater than <em style="font: inherit;">10%</em> of the Company’s revenues. For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, </span><span style="-sec-ix-hidden:c120650901">two</span><span style="background-color:#ffffff;"> and <span style="-sec-ix-hidden:c120650903">four</span> significant customers accounted for $</span>1,358,000<span style="background-color:#ffffff;"> or </span>69.4%<span style="background-color:#ffffff;"> and $</span>297,000<span style="background-color:#ffffff;"> or </span>74.8%<span style="background-color:#ffffff;">% of revenue, respectively. For the </span><em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, </span><span style="-sec-ix-hidden:c120650913"><span style="-sec-ix-hidden:c120651048">two</span></span><span style="background-color:#ffffff;"> significant customers accounted for $</span>1,450,000<span style="background-color:#ffffff;"> or </span>54.1%<span style="background-color:#ffffff;"> and $1,137,000 or 51.4% of revenue, respectively. </span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="background-color:#ffffff;">As of </span><em style="font: inherit;"> September 30, 2024</em><span style="background-color:#ffffff;"> and </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, accounts receivable was from <span style="-sec-ix-hidden:c120650920">nine</span></span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650921">thirteen</span><span style="background-color:#ffffff;"> customers, of which, </span><span style="-sec-ix-hidden:c120650922">four</span><span style="background-color:#ffffff;"> customers accounted for $</span>262,000<span style="background-color:#ffffff;"> or </span>74.1%<span style="background-color:#ffffff;"> and $336,000 or 72.0% of total accounts receivable, respectively. The loss of business from <em style="font: inherit;">one</em> or a combination of the Company’s customers could adversely affect its operations.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><span style="background-color:#ffffff;">The Company conducts operations in the Netherlands through its foreign subsidiary and generates a portion of its revenues from customers that are located outside of the United States. For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, the Company had </span><span style="-sec-ix-hidden:c120650932">four</span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650934">three</span><span style="background-color:#ffffff;"> customers outside of the United States (i.e., European customers) that accounted for </span>$550,000<span style="background-color:#ffffff;"> or </span>28.1%<span style="background-color:#ffffff;"> and </span>$127,000<span style="background-color:#ffffff;"> or </span>32.0%<span style="background-color:#ffffff;"> of revenue, respectively. For the </span><em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, the Company had </span><span style="-sec-ix-hidden:c120650942">eight</span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650944">four</span><span style="background-color:#ffffff;"> customers outside of the United States (i.e., European customers) that accounted for </span>$854,000<span style="background-color:#ffffff;"> or </span>31.9%<span style="background-color:#ffffff;"> and </span>$314,000<span style="background-color:#ffffff;"> or </span>14.2%<span style="background-color:#ffffff;"> of revenue, respectively. </span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><span style="background-color:#ffffff;">As of </span><em style="font: inherit;"> September 30, 2024</em><span style="background-color:#ffffff;"> and </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, the Company had </span>five<span style="background-color:#ffffff;"> and <span style="-sec-ix-hidden:c120650951">six</span> </span><span style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;">cus</span></span><span style="background-color:#ffffff;">tomers outside of the United States (i.e., European customers) that accounted for </span>$167,000<span style="background-color:#ffffff;"> </span><span style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;">or </span>47.2%<span style="background-color:#ffffff;"> and </span></span>$213,000<span style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;"> or </span></span>45.6%<span style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;"> of accou</span></span><span style="background-color:#ffffff;">nts receivable, respectively.</span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="background-color:#ffffff;">The Company uses several contract research organizations (“CROs”) to conduct its research projects. For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, </span><span style="-sec-ix-hidden:c120650960">two</span><span style="background-color:#ffffff;"> and <span style="-sec-ix-hidden:c120650961">three</span> CROs accounted for </span>$690,000<span style="background-color:#ffffff;"> or </span>94.6%<span style="background-color:#ffffff;"> and </span>$977,000<span style="background-color:#ffffff;"> or </span>93.4%<span style="background-color:#ffffff;"> of total research services we purchased, respectively. For the </span><em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em><span style="background-color:#ffffff;">, <span style="-sec-ix-hidden:c120650970">two</span> and <span style="-sec-ix-hidden:c120650971">three</span> CROs accounted for </span>$ 1,647,000<span style="background-color:#ffffff;"> or </span>92.0%<span style="background-color:#ffffff;"> and </span>$3,639,000<span style="background-color:#ffffff;"> or </span>96.4%<span style="background-color:#ffffff;"> of total research services we purchased, respectively. As of </span><em style="font: inherit;"> September 30, 2024</em><span style="background-color:#ffffff;"> and </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, </span><span style="-sec-ix-hidden:c120650977">two</span><span style="background-color:#ffffff;"> and </span><span style="-sec-ix-hidden:c120650978">three</span><span style="background-color:#ffffff;"> CROs accounted for </span>$341,000<span style="background-color:#ffffff;"> or </span>60.8%<span style="background-color:#ffffff;"> and $620,000 or 94.4% of accounts payable, respectively. The loss of <em style="font: inherit;">one</em> CRO or a combination of the Company’s CROs could adversely affect its operations.</span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="margin: 0pt 0pt 0pt 18pt; font-family: "Times New Roman"; font-size: 10pt;"></p>
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	352934	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	466159	usd
CY2024Q3	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	376608	usd
CY2023Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	575436	usd
CY2024Q3	dyai	Legal Expenses Payable Current LegalExpensesPayableCurrent	130974	usd
CY2023Q4	dyai	Legal Expenses Payable Current LegalExpensesPayableCurrent	1957	usd
CY2024Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	54215	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	79052	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	561797	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	656445	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	442604	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	561720	usd
CY2024Q3	dyai	Accrued Research And Development In Process Current AccruedResearchAndDevelopmentInProcessCurrent	372456	usd
CY2023Q4	dyai	Accrued Research And Development In Process Current AccruedResearchAndDevelopmentInProcessCurrent	274080	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	210004	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11360	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11360	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	839420	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1057164	usd
CY2024Q3	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	336068000	usd
CY2023Q3	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	556042000	usd
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	1119502000	usd
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	1947228000	usd
CY2024Q3	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	121081000	usd
CY2023Q3	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	147426000	usd
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	334297000	usd
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	447034000	usd
CY2024Q3	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	3092000	usd
CY2023Q3	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	12883000	usd
	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	44794000	usd
	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	50207000	usd
CY2024Q3	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	460241000	usd
CY2023Q3	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	716351000	usd
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1498593000	usd
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	2444469000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	16400000	usd
	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1	pure
CY2024Q3	us-gaap	Cash Cash	1095858	usd
CY2024Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	4825756	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5921614	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5921614	usd
CY2024Q3	dyai	Cash Cash Equivalents And Investments Fair Value CashCashEquivalentsAndInvestmentsFairValue	9923648	usd
CY2024Q3	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0	usd
CY2024Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1202	usd
CY2024Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	-0	usd
CY2024Q3	us-gaap	Investments And Cash InvestmentsAndCash	9922446	usd
CY2023Q4	us-gaap	Cash Cash	25775	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6489253	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6515028	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515028	usd
CY2023Q4	dyai	Cash Cash Equivalents And Investments Fair Value CashCashEquivalentsAndInvestmentsFairValue	7263133	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	185	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	7263318	usd
CY2024Q3	dyai	Debt Securities Heldtomaturity Securities Purchased Discount DebtSecuritiesHeldtomaturitySecuritiesPurchasedDiscount	9023	usd
CY2023Q3	dyai	Debt Securities Heldtomaturity Securities Purchased Discount DebtSecuritiesHeldtomaturitySecuritiesPurchasedDiscount	1148	usd
	dyai	Debt Securities Heldtomaturity Securities Purchased Discount DebtSecuritiesHeldtomaturitySecuritiesPurchasedDiscount	70495	usd
	dyai	Debt Securities Heldtomaturity Securities Purchased Discount DebtSecuritiesHeldtomaturitySecuritiesPurchasedDiscount	33982	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0356	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0461	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5469247
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.08
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M28D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	322738	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	837600
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	30000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	358500
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.1
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	73312
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.73
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5845035
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.96
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M25D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3500	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4458123
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M17D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3500	usd
CY2024Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	9000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	50000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	247390	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	281307	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	851471	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	946262	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	247390	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	281307	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	851471	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	946262	usd
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	335195
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	usd

Files In Submission

Name	View Source	Status
0001437749-24-034545-index-headers.html	Edgar Link	pending
0001437749-24-034545-index.html	Edgar Link	pending
0001437749-24-034545.txt	Edgar Link	pending
0001437749-24-034545-xbrl.zip	Edgar Link	pending
dyai-20240930.xsd	Edgar Link	pending
dyai20240930c_10q.htm	Edgar Link	pending
ex_721717.htm	Edgar Link	pending
ex_721718.htm	Edgar Link	pending
ex_721719.htm	Edgar Link	pending
ex_721720.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dyai-20240930_def.xml	Edgar Link	unprocessable
dyai-20240930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dyai20240930c_10q_htm.xml	Edgar Link	completed
dyai-20240930_cal.xml	Edgar Link	unprocessable
dyai-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
DYADIC INTERNATIONAL INC Stock $dyai

2024 Q4 Form 10-Q Financial Statement

#000143774924034545 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI DYADIC INTERNATIONAL INC Stock $dyai

2024 Q4 Form 10-Q Financial Statement

#000143774924034545 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
DYADIC INTERNATIONAL INC Stock $dyai